|
|
|
|
|
|
Early, Late, PrEP, PEP |
Covid Analysis (Preprint) (meta analysis) |
meta-analysis |
Vitamin A for COVID-19: real-time meta analysis of 11 studies |
Details
• Statistically significant improvements are seen for recovery, cases, and viral clearance. 4 studies from 3 independent teams in 3 different countries show statistically significant improvements in isolation (2 for the most serious outco.. |
|
Details
Source
PDF
Early, Late, PrEP, PEP
Early, Late, PrEP, PEP
|
Vitamin A for COVID-19: real-time meta analysis of 11 studies |
Covid Analysis (Preprint) (meta analysis) |
• Statistically significant improvements are seen for recovery, cases, and viral clearance. 4 studies from 3 independent teams in 3 different countries show statistically significant improvements in isolation (2 for the most serious outcome).• Meta analysis using the most serious outcome reported shows 50% [-9‑77%] improvement, without reaching statistical significance. Results are better for Randomized Controlled Trials, similar after exclusions, and better for peer-reviewed studies. Results are consistent with early treatment being more effective than late treatment. • Sufficiency studies, analyzing outcomes based on serum levels, show 73% [51‑85%] improvement for patients with higher vitamin A levels (3 studies).• While many treatments have some level of efficacy, they do not replace vaccines and other measures to avoid infection. Only 25% of vitamin A studies show zero events in the treatment arm. Multiple treatments are typically used in combination, and other treatments may be more effective.• No treatment, vaccine, or intervention is 100% available and effective for all variants. All practical, effective, and safe means should be used. Denying the efficacy of treatments increases mortality, morbidity, collateral damage, and endemic risk.• All data to reproduce this paper and sources are in the appendix.
Covid Analysis et al., 8/12/2022, preprint, 1 author.
|
Submit Corrections or Comments
|
|
In Vitro |
Tong et al., mBio, doi:10.1128/mbio.01485-22 (In Vitro) |
In Vitro |
A Retinol Derivative Inhibits SARS-CoV-2 Infection by Interrupting Spike-Mediated Cellular Entry |
Details
In Vitro study showing all-trans retinoic acid, a vitamin A derivative, has potent antiviral activity against SARS-CoV-2 in both human cell lines and human organoids of the lower respiratory tract. |
|
Details
Source
PDF
In Vitro
In Vitro
|
A Retinol Derivative Inhibits SARS-CoV-2 Infection by Interrupting Spike-Mediated Cellular Entry |
Tong et al., mBio, doi:10.1128/mbio.01485-22 (In Vitro) |
In Vitro study showing all-trans retinoic acid, a vitamin A derivative, has potent antiviral activity against SARS-CoV-2 in both human cell lines and human organoids of the lower respiratory tract.
Tong et al., 7/13/2022, China, peer-reviewed, 14 authors.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
|
Submit Corrections or Comments
|
|
In Silico |
Chakraborty et al., Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105788 |
In Silico |
In-silico screening and in-vitro assay show the antiviral effect of Indomethacin against SARS-CoV-2 |
Details
In Silico study predicting indomethacin and vitamin A can bind critical host and viral proteins for SARS-CoV-2 interaction, and may be able to compensate for gene expressions changes related to SARS-CoV-2. |
|
Details
Source
PDF
In Silico
In Silico
|
In-silico screening and in-vitro assay show the antiviral effect of Indomethacin against SARS-CoV-2 |
Chakraborty et al., Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105788 |
In Silico study predicting indomethacin and vitamin A can bind critical host and viral proteins for SARS-CoV-2 interaction, and may be able to compensate for gene expressions changes related to SARS-CoV-2.
Chakraborty et al., 6/30/2022, peer-reviewed, 11 authors.
In Silico studies are an important part of preclinical research, however results may be very different in vivo.
|
Submit Corrections or Comments
|
|
Levels |
RodanSarohan et al., Clinical Nutrition Open Science, doi:10.1016/j.nutos.2022.05.007 |
Retinol Depletion in COVID-19 |
Details
Comparison of 27 COVID-19 ICU patients and 23 control patients, showing significantly lower vitamin A levels in COVID-19 patients. |
|
Details
Source
PDF
Levels
Analysis of outcomes based on serum levels
|
Retinol Depletion in COVID-19 |
RodanSarohan et al., Clinical Nutrition Open Science, doi:10.1016/j.nutos.2022.05.007 |
Comparison of 27 COVID-19 ICU patients and 23 control patients, showing significantly lower vitamin A levels in COVID-19 patients.
RodanSarohan et al., 5/28/2022, retrospective, Turkey, peer-reviewed, 5 authors.
|
Submit Corrections or Comments
|
|
PrEPPEP |
Galmés et al., Nutrients, doi:10.3390/nu14112254 |
Suboptimal Consumption of Relevant Immune System Micronutrients Is Associated with a Worse Impact of COVID-19 in Spanish Populations |
Details
Ecological study in Spain, showing lower intake of vitamin D, A, B9, and zinc in regions with the highest COVID-19 incidence and mortality. Vitamin D intake was associated with lower prevalence, incidence, and a combined incidence+mortali.. |
|
Details
Source
PDF
Prophylaxis study
Prophylaxis study
|
Suboptimal Consumption of Relevant Immune System Micronutrients Is Associated with a Worse Impact of COVID-19 in Spanish Populations |
Galmés et al., Nutrients, doi:10.3390/nu14112254 |
Ecological study in Spain, showing lower intake of vitamin D, A, B9, and zinc in regions with the highest COVID-19 incidence and mortality.Vitamin D intake was associated with lower prevalence, incidence, and a combined incidence+mortality index. Vitamin A intake was correlated with lower incidence, ∆incidence, and combined incidence+mortality, while not reaching statistical significance (p = 0.09, 0.07, 0.06). Vitamin B9, B12, and zinc were associated with lower ∆incidence.Authors analyze 10 vitamins and minerals endorsed by the European Food Safety Authority (EFSA) as having sufficient evidence for a causal relationship between intake and optimal immune system function: vitamins D, A, C, B6, B9, B12, zinc, copper, iron, and selenium.The intake of all 10 showed an inverse correlation with ∆incidence and combined incidence+mortality (statistically significant only as shown).
Galmés et al., 5/27/2022, Spain, peer-reviewed, 3 authors.
|
Submit Corrections or Comments
|
|
Levels |
Vollenberg et al., Nutrients, doi:10.3390/nu14102007 |
Significantly Reduced Retinol Binding Protein 4 (RBP4) Levels in Critically Ill COVID-19 Patientshttps://www.mdpi.com/2072-6643/14/10/2007 |
Details
Prospective study of 59 hospitalized COVID-19 patients and 20 matched convalescent control patients in Germany, showing significantly lower vitamin A levels in COVID-19 patients. |
|
Details
Source
PDF
Levels
Analysis of outcomes based on serum levels
|
Significantly Reduced Retinol Binding Protein 4 (RBP4) Levels in Critically Ill COVID-19 Patientshttps://www.mdpi.com/2072-6643/14/10/2007 |
Vollenberg et al., Nutrients, doi:10.3390/nu14102007 |
Prospective study of 59 hospitalized COVID-19 patients and 20 matched convalescent control patients in Germany, showing significantly lower vitamin A levels in COVID-19 patients.
Vollenberg et al., 5/10/2022, prospective, Germany, peer-reviewed, 4 authors.
|
Submit Corrections or Comments
|
|
Levels |
Voelkle et al., Nutrients, doi:10.3390/nu14091862 |
death/ICU, ↓76.2%, p=0.004 |
Prevalence of Micronutrient Deficiencies in Patients Hospitalized with COVID-19: An Observational Cohort Study |
Details
Prospective study of 57 consecutive hospitalized COVID-19 patients in Switzerland, showing higher risk of mortality/ICU admission with vitamin A, vitamin D, and zinc deficiency, with statistical significance only for vitamin A and zinc. A.. |
|
Details
Source
PDF
Levels
Analysis of outcomes based on serum levels
|
Prevalence of Micronutrient Deficiencies in Patients Hospitalized with COVID-19: An Observational Cohort Study |
Voelkle et al., Nutrients, doi:10.3390/nu14091862 |
Prospective study of 57 consecutive hospitalized COVID-19 patients in Switzerland, showing higher risk of mortality/ICU admission with vitamin A, vitamin D, and zinc deficiency, with statistical significance only for vitamin A and zinc. Adjustments only considered age.
risk of death/ICU, 76.2% lower, RR 0.24, p = 0.004, treatment 4 of 35 (11.4%), control 11 of 22 (50.0%), NNT 2.6, adjusted, OR converted to RR.
|
Voelkle et al., 4/30/2022, prospective, Switzerland, peer-reviewed, median age 67.0, 9 authors, study period 17 March, 2020 - 30 April, 2020.
|
Submit Corrections or Comments
|
|
In Silico |
Pandya et al., Informatics in Medicine Unlocked, doi:10.1016/j.imu.2022.100951 |
In Silico |
Unravelling Vitamin B12 as a potential inhibitor against SARS-CoV-2: A computational approach |
Details
In Silico study showing significant interaction with SARS-CoV-2 targets for multiple vitamins. |
|
Details
Source
PDF
In Silico
In Silico
|
Unravelling Vitamin B12 as a potential inhibitor against SARS-CoV-2: A computational approach |
Pandya et al., Informatics in Medicine Unlocked, doi:10.1016/j.imu.2022.100951 |
In Silico study showing significant interaction with SARS-CoV-2 targets for multiple vitamins.
Pandya et al., 4/20/2022, peer-reviewed, 9 authors.
In Silico studies are an important part of preclinical research, however results may be very different in vivo.
|
Submit Corrections or Comments
|
|
Review |
DiGuilio et al., International Journal of Molecular Sciences, doi:10.3390/ijms23062995 (Review) |
review |
Micronutrient Improvement of Epithelial Barrier Function in Various Disease States: A Case for Adjuvant Therapy |
Details
Review of epithelial and endothelial barrier compromise and associated disease risk including COVID-19, and the potential benefits of vitamin A, vitamin D, and zinc for improving barrier function. |
|
Details
Source
PDF
Review
Review
|
Micronutrient Improvement of Epithelial Barrier Function in Various Disease States: A Case for Adjuvant Therapy |
DiGuilio et al., International Journal of Molecular Sciences, doi:10.3390/ijms23062995 (Review) |
Review of epithelial and endothelial barrier compromise and associated disease risk including COVID-19, and the potential benefits of vitamin A, vitamin D, and zinc for improving barrier function.
DiGuilio et al., 3/10/2022, peer-reviewed, 8 authors.
|
Submit Corrections or Comments
|
|
Late |
Elkazzaz et al., medRxiv, doi:10.1101/2022.03.05.22271959 (Preprint) |
death, ↓85.7%, p=0.23 |
13 cis retinoic acid improved the outcomes of COVID-19 patients. A randomized clinical trial |
Details
RCT with 20 13-cis-retinoic acid patients and 20 control patients, showing faster recovery and viral clearance with treatment. Aerosolized 13-cis-retinoic acid with increasing dose from 0.2 mg/kg/day to 4 mg/kg/day for 14 days, plus oral.. |
|
Details
Source
PDF
Late treatment study
Late treatment study
|
13 cis retinoic acid improved the outcomes of COVID-19 patients. A randomized clinical trial |
Elkazzaz et al., medRxiv, doi:10.1101/2022.03.05.22271959 (Preprint) |
RCT with 20 13-cis-retinoic acid patients and 20 control patients, showing faster recovery and viral clearance with treatment. Aerosolized 13-cis-retinoic acid with increasing dose from 0.2 mg/kg/day to 4 mg/kg/day for 14 days, plus oral 13-cis-retinoic acid 20 mg/day. 13-cis retinoic acid is a synthetic vitamin A derivative, and is teratogenic. NCT04353180.
risk of death, 85.7% lower, RR 0.14, p = 0.23, treatment 0 of 20 (0.0%), control 3 of 20 (15.0%), NNT 6.7, relative risk is not 0 because of continuity correction due to zero events.
|
risk of ICU admission, 66.7% lower, RR 0.33, p = 0.24, treatment 2 of 20 (10.0%), control 6 of 20 (30.0%), NNT 5.0.
|
recovery time, 35.4% lower, relative time 0.65, p < 0.001, treatment mean 16.3 (±4.5) n=20, control mean 25.23 (±4.72) n=20.
|
time to viral-, 44.0% lower, relative time 0.56, p < 0.001, treatment mean 13.36 (±1.49) n=20, control mean 23.85 (±4.0) n=20.
|
Elkazzaz et al., 3/8/2022, Randomized Controlled Trial, Egypt, preprint, 4 authors, study period June 2020 - August 2020, trial NCT04353180 (history).
|
Submit Corrections or Comments
|
|
PrEPPEP |
Nimer et al., Bosnian Journal of Basic Medical Sciences, doi:10.17305/bjbms.2021.7009 |
hosp., ↓21.2%, p=0.40 |
The impact of vitamin and mineral supplements usage prior to COVID-19 infection on disease severity and hospitalization |
Details
Retrospective survey based analysis of 2,148 COVID-19 recovered patients in Jordan, showing no significant differences in the risk of severity and hospitalization with vitamin A prophylaxis. |
|
Details
Source
PDF
Prophylaxis study
Prophylaxis study
|
The impact of vitamin and mineral supplements usage prior to COVID-19 infection on disease severity and hospitalization |
Nimer et al., Bosnian Journal of Basic Medical Sciences, doi:10.17305/bjbms.2021.7009 |
Retrospective survey based analysis of 2,148 COVID-19 recovered patients in Jordan, showing no significant differences in the risk of severity and hospitalization with vitamin A prophylaxis.
risk of hospitalization, 21.2% lower, RR 0.79, p = 0.40, treatment 15 of 144 (10.4%), control 204 of 2,004 (10.2%), adjusted, OR converted to RR, multivariable.
|
risk of severe case, 20.8% lower, RR 0.79, p = 0.36, treatment 17 of 144 (11.8%), control 243 of 2,004 (12.1%), adjusted, OR converted to RR, multivariable.
|
Nimer et al., 2/28/2022, retrospective, Jordan, peer-reviewed, survey, 4 authors, study period March 2021 - July 2021.
|
Submit Corrections or Comments
|
|
Late |
Beigmohammadi et al., Trials, doi:10.1186/s13063-021-05795-4 |
death, ↓88.9%, p=0.11 |
The effect of supplementation with vitamins A, B, C, D, and E on disease severity and inflammatory responses in patients with COVID-19: a randomized clinical trial |
Details
Small RCT 60 ICU patients in Iran, 30 treated with vitamins A, B, C, D, and E, showing significant improvement in SOFA score and several inflammatory markers at day 7 with treatment. 5,000 IU vitamin A daily, 600,000 IU vitamin D once, 30.. |
|
Details
Source
PDF
Late treatment study
Late treatment study
|
The effect of supplementation with vitamins A, B, C, D, and E on disease severity and inflammatory responses in patients with COVID-19: a randomized clinical trial |
Beigmohammadi et al., Trials, doi:10.1186/s13063-021-05795-4 |
Small RCT 60 ICU patients in Iran, 30 treated with vitamins A, B, C, D, and E, showing significant improvement in SOFA score and several inflammatory markers at day 7 with treatment.5,000 IU vitamin A daily, 600,000 IU vitamin D once, 300 IU of vitamin E twice a day, 500 mg vitamin C four times a day, and one ampule daily of B vitamins [thiamine nitrate 3.1 mg, sodium riboflavin phosphate 4.9 mg (corresponding to vitamin B2 3.6 mg), nicotinamide 40 mg, pyridoxine hydrochloride 4.9 mg (corresponding to vitamin B6 4.0 mg), sodium pantothenate 16.5 mg (corresponding to pantothenic acid 15 mg), sodium ascorbate 113 mg (corresponding to vitamin C 100 mg), biotin 60 μg, folic acid 400 μg, and cyanocobalamin 5 μg]. IRCT20200319046819N [irct.ir].
risk of death, 88.9% lower, RR 0.11, p = 0.11, treatment 0 of 30 (0.0%), control 4 of 30 (13.3%), NNT 7.5, relative risk is not 0 because of continuity correction due to zero events.
|
risk of hospitalization >7 days, 41.0% lower, RR 0.59, p = 0.25, treatment 4 of 30 (13.3%), control 16 of 30 (53.3%), NNT 2.5, adjusted, OR converted to RR.
|
relative SOFA score @day 7, 45.5% better, RR 0.55, p < 0.001, treatment 30, control 30.
|
Beigmohammadi et al., 11/14/2021, Single Blind Randomized Controlled Trial, Iran, peer-reviewed, 6 authors, this trial uses multiple treatments in the treatment arm (combined with vitamins B, C, D, E) - results of individual treatments may vary.
|
Submit Corrections or Comments
|
|
In Vitro |
Morita et al., Viruses, doi:10.3390/v13081669 (In Vitro) |
In Vitro |
All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity |
Details
In Vitro and In Silico study showing that all-trans retinoic acid is a potent SARS-CoV-2 3CLpro inhibitor, inhibits SARS-CoV-2 replication in VeroE6/TMPRSS2 cells, and is effective against alpha, beta, gamma, and delta variants in Calu-3 .. |
|
Details
Source
PDF
In Vitro
In Vitro
|
All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity |
Morita et al., Viruses, doi:10.3390/v13081669 (In Vitro) |
In Vitro and In Silico study showing that all-trans retinoic acid is a potent SARS-CoV-2 3CLpro inhibitor, inhibits SARS-CoV-2 replication in VeroE6/TMPRSS2 cells, and is effective against alpha, beta, gamma, and delta variants in Calu-3 cells.
Morita et al., 8/23/2021, peer-reviewed, 9 authors.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
|
Submit Corrections or Comments
|
|
Levels |
Tepasse et al., Nutrients, doi:10.3390/nu13072173 |
death, ↓69.7%, p=0.04 |
Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis |
Details
Prospective analysis of 40 hospitalized patients and 47 age-matched convalescent patients, showing significantly lower vitamin A levels in critical patients, and significantly lower vitamin A levels in hospitalized patients vs. controls. .. |
|
Details
Source
PDF
Levels
Analysis of outcomes based on serum levels
|
Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis |
Tepasse et al., Nutrients, doi:10.3390/nu13072173 |
Prospective analysis of 40 hospitalized patients and 47 age-matched convalescent patients, showing significantly lower vitamin A levels in critical patients, and significantly lower vitamin A levels in hospitalized patients vs. controls. Low vitamin A levels were significantly associated with ARDS and mortality in hospitalized patients.
risk of death, 69.7% lower, RR 0.30, p = 0.04, treatment 4 of 29 (13.8%), control 5 of 11 (45.5%), NNT 3.2, OR converted to RR, >2mg/L, logistic regression.
|
risk of progression, 45.2% lower, RR 0.55, p = 0.048, treatment 13 of 29 (44.8%), control 9 of 11 (81.8%), NNT 2.7, OR converted to RR, progression to ARDS, >2mg/L, logistic regression.
|
Tepasse et al., 6/24/2021, prospective, Germany, peer-reviewed, 8 authors.
|
Submit Corrections or Comments
|
|
PrEPPEP |
Holt et al., Thorax, doi:10.1136/thoraxjnl-2021-217487 |
cases, ↓56.3%, p=0.41 |
Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK) |
Details
Prospective survey-based study with 15,227 people in the UK, showing lower risk of COVID-19 cases with vitamin A, vitamin D, zinc, selenium, probiotics, and inhaled corticosteroids; and higher risk with metformin and vitamin C. Statistica.. |
|
Details
Source
PDF
Prophylaxis study
Prophylaxis study
|
Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK) |
Holt et al., Thorax, doi:10.1136/thoraxjnl-2021-217487 |
Prospective survey-based study with 15,227 people in the UK, showing lower risk of COVID-19 cases with vitamin A, vitamin D, zinc, selenium, probiotics, and inhaled corticosteroids; and higher risk with metformin and vitamin C. Statistical significance was not reached for any of these. Except for vitamin D, the results for treatments we follow were only adjusted for age, sex, duration of participation, and test frequency. NCT04330599. COVIDENCE UK.
risk of case, 56.3% lower, RR 0.44, p = 0.41, treatment 1 of 91 (1.1%), control 445 of 15,136 (2.9%), NNT 54, adjusted, OR converted to RR, minimally adjusted, group sizes approximated.
|
Excluded in after exclusion results of meta analysis:
significant unadjusted confounding possible.
Holt et al., 3/30/2021, prospective, United Kingdom, peer-reviewed, 34 authors, study period 1 May, 2020 - 5 February, 2021, trial NCT04330599 (history) (COVIDENCE UK).
|
Submit Corrections or Comments
|
|
Levels |
Muhammad et al., SAGE Open Medicine, doi:10.1177/2050312121991246 |
Deficiency of antioxidants and increased oxidative stress in COVID-19 patients: A cross-sectional comparative study in Jigawa, Northwestern Nigeria |
Details
Case control study with 50 symptomatic COVID-19 patients and 21 healthy controls in Nigeria, showing that COVID-19 patients had significantly lower levels of selenium and zinc, and vitamins A, C, and E. Control patients were younger than .. |
|
Details
Source
PDF
Levels
Analysis of outcomes based on serum levels
|
Deficiency of antioxidants and increased oxidative stress in COVID-19 patients: A cross-sectional comparative study in Jigawa, Northwestern Nigeria |
Muhammad et al., SAGE Open Medicine, doi:10.1177/2050312121991246 |
Case control study with 50 symptomatic COVID-19 patients and 21 healthy controls in Nigeria, showing that COVID-19 patients had significantly lower levels of selenium and zinc, and vitamins A, C, and E. Control patients were younger than COVID-19 patients. The p value for zinc in Table 2 appears to be a typo.
Muhammad et al., 2/1/2021, Nigeria, peer-reviewed, 8 authors.
|
Submit Corrections or Comments
|
|
Late |
Sarohan et al., medRxiv, doi:10.1101/2021.01.30.21250844 (Preprint) |
death, ↑282.5%, p=0.001 |
Retinol Depletion in Severe COVID-19 |
Details
Retrospective 27 severe COVID-19 patients and 23 non-COVID-19 patients, showing signifcantly lower vitamin A levels in COVID-19 patients (0.37mg/L vs. 0.52 mg/L, p<0.001). 10 of 27 COVID-19 patients received vitamin A, with higher mortali.. |
|
Details
Source
PDF
Late treatment study
Late treatment study
|
Retinol Depletion in Severe COVID-19 |
Sarohan et al., medRxiv, doi:10.1101/2021.01.30.21250844 (Preprint) |
Retrospective 27 severe COVID-19 patients and 23 non-COVID-19 patients, showing signifcantly lower vitamin A levels in COVID-19 patients (0.37mg/L vs. 0.52 mg/L, p<0.001). 10 of 27 COVID-19 patients received vitamin A, with higher mortality. Group details are not provided but authors note that 8 of 10 had comorbidities.
risk of death, 282.5% higher, RR 3.83, p = 0.001, treatment 9 of 10 (90.0%), control 4 of 17 (23.5%).
|
Excluded in after exclusion results of meta analysis:
unadjusted results with no group details.
Sarohan et al., 2/1/2021, retrospective, Turkey, preprint, 4 authors.
|
Submit Corrections or Comments
|
|
Early |
Al-Sumiadai, Systematic Reviews in Pharmacy, 12:1 (Preprint) |
progression, ↓66.7%, p=0.27 |
Therapeutic effect of vitamin A on COVID-19 patients and its prophylactic effect on contacts |
Details
Treatment and prophylaxis studies of vitamin A in Iraq. The treatment study contained 100 patients, 50 treated with 200,000IU vitamin A for two days, showing lower progression to severe disease, and shorter duration of symptoms. The proph.. |
|
Details
Source
PDF
Early treatment study
Early treatment study
|
Therapeutic effect of vitamin A on COVID-19 patients and its prophylactic effect on contacts |
Al-Sumiadai, Systematic Reviews in Pharmacy, 12:1 (Preprint) |
Treatment and prophylaxis studies of vitamin A in Iraq.The treatment study contained 100 patients, 50 treated with 200,000IU vitamin A for two days, showing lower progression to severe disease, and shorter duration of symptoms.The prophylaxis study contained 209 contacts of COVID-19 patients, 97 treated with vitamin A, showing significantly lower cases with treatment, and shorter duration of symptoms.
risk of progression, 66.7% lower, RR 0.33, p = 0.27, treatment 2 of 50 (4.0%), control 6 of 50 (12.0%), NNT 13, progression to severe disease.
|
recovery time, 37.5% lower, relative time 0.62, treatment 50, control 50.
|
Al-Sumiadai et al., 1/31/2021, prospective, Iraq, preprint, 3 authors.
|
Submit Corrections or Comments
|
|
Review |
Stephensen et al., British Journal of Nutrition, doi:10.1017/S0007114521000246 (Review) |
review |
Vitamin A in resistance to and recovery from infection: relevance to SARS-CoV2 |
Details
Review of the potential benefits of vitamin A for COVID-19, including maintaining innate and adaptive immunity, minimizing inflammation, supporting repair of respiratory epithelium and preventing fibrosis, and counteracting adverse effect.. |
|
Details
Source
PDF
Review
Review
|
Vitamin A in resistance to and recovery from infection: relevance to SARS-CoV2 |
Stephensen et al., British Journal of Nutrition, doi:10.1017/S0007114521000246 (Review) |
Review of the potential benefits of vitamin A for COVID-19, including maintaining innate and adaptive immunity, minimizing inflammation, supporting repair of respiratory epithelium and preventing fibrosis, and counteracting adverse effects of SARS-CoV-2 on the angiotensin system.
Stephensen et al., 1/20/2021, peer-reviewed, 2 authors.
|
Submit Corrections or Comments
|
|
Early |
Al-Sumiadai et al., EurAsian Journal of Biosciences, 14:7347-7350 |
death, ↓85.7%, p=0.002 |
Therapeutic effect of Vitamin A on severe COVID-19 patients |
Details
Retrospective 70 severe condition patients treated with vitamin A (200,000IU for two days), salbutamol, and budesonide, and 70 patients not treated with vitamin A, showing significantly lower mortality with the addition of vitamin A. |
|
Details
Source
PDF
Early treatment study
Early treatment study
|
Therapeutic effect of Vitamin A on severe COVID-19 patients |
Al-Sumiadai et al., EurAsian Journal of Biosciences, 14:7347-7350 |
Retrospective 70 severe condition patients treated with vitamin A (200,000IU for two days), salbutamol, and budesonide, and 70 patients not treated with vitamin A, showing significantly lower mortality with the addition of vitamin A.
risk of death, 85.7% lower, RR 0.14, p = 0.002, treatment 2 of 70 (2.9%), control 14 of 70 (20.0%), NNT 5.8.
|
Excluded in after exclusion results of meta analysis:
minimal details of groups provided.
Al-Sumiadai et al., 12/31/2020, retrospective, Iraq, peer-reviewed, 3 authors.
|
Submit Corrections or Comments
|
|
Review |
Midha et al., Reviews in Medical Virology, doi:10.1002/rmv.2204 (Review) |
review |
Mega doses of retinol: A possible immunomodulation in Covid-19 illness in resource-limited settings |
Details
Review of the potential benefits of vitamin A for COVID-19, including the effect of vitamin A on ACE2 expression in the respiratory tract, potentially improving the generation of protective immune responses to vaccines, and dosage and saf.. |
|
Details
Source
PDF
Review
Review
|
Mega doses of retinol: A possible immunomodulation in Covid-19 illness in resource-limited settings |
Midha et al., Reviews in Medical Virology, doi:10.1002/rmv.2204 (Review) |
Review of the potential benefits of vitamin A for COVID-19, including the effect of vitamin A on ACE2 expression in the respiratory tract, potentially improving the generation of protective immune responses to vaccines, and dosage and safety analysis.
Midha et al., 12/31/2020, peer-reviewed, 4 authors.
|
Submit Corrections or Comments
|
|
Levels |
Tomasa-Irriguible et al., Metabolites, doi:10.3390/metabo11090565 (preprint 10/26/2020) |
ventilation, ↓71.4%, p=0.001 |
Low Levels of Few Micronutrients May Impact COVID-19 Disease Progression: An Observational Study on the First Wave |
Details
Retrospective 120 hospitalized patients in Spain showing vitamin A deficiency associated with higher ICU admission. |
|
Details
Source
PDF
Levels
Analysis of outcomes based on serum levels
|
Low Levels of Few Micronutrients May Impact COVID-19 Disease Progression: An Observational Study on the First Wave |
Tomasa-Irriguible et al., Metabolites, doi:10.3390/metabo11090565 (preprint 10/26/2020) |
Retrospective 120 hospitalized patients in Spain showing vitamin A deficiency associated with higher ICU admission.
risk of mechanical ventilation, 71.4% lower, RR 0.29, p = 0.001, treatment 4 of 34 (11.8%), control 48 of 86 (55.8%), NNT 2.3, adjusted, OR converted to RR, ≥0.3 mg/L, multivariate logistic regression.
|
risk of ICU admission, 61.3% lower, RR 0.39, p = 0.004, treatment 6 of 34 (17.6%), control 54 of 86 (62.8%), NNT 2.2, adjusted, OR converted to RR, ≥0.3 mg/L, multivariate logistic regression.
|
Tomasa-Irriguible et al., 10/26/2020, retrospective, Spain, peer-reviewed, 7 authors.
|
Submit Corrections or Comments
|
|
PrEPPEP |
Galmés et al., Nutrients, doi:10.3390/nu12092738 |
Current State of Evidence: Influence of Nutritional and Nutrigenetic Factors on Immunity in the COVID-19 Pandemic Framework |
Details
Ecological study of European countries analyzing 10 vitamins and minerals endorsed by the European Food Safety Authority as having sufficient evidence for a causal relationship between intake and optimal immune system function: vitamins D.. |
|
Details
Source
PDF
Prophylaxis study
Prophylaxis study
|
Current State of Evidence: Influence of Nutritional and Nutrigenetic Factors on Immunity in the COVID-19 Pandemic Framework |
Galmés et al., Nutrients, doi:10.3390/nu12092738 |
Ecological study of European countries analyzing 10 vitamins and minerals endorsed by the European Food Safety Authority as having sufficient evidence for a causal relationship between intake and optimal immune system function: vitamins D, A, C, B6, B9, B12, zinc, copper, iron, and selenium.Intake levels of all 10 showed an inverse correlation with the relative mortality rate, while all except vitamin B6 and selenium showed an inverse correlation with incidence and mortality. Most individual correlations did not reach statistical significance. Authors note greater association in populations genetically predisposed towards lower micronutrient status.
Galmés et al., 9/8/2020, retrospective, peer-reviewed, 3 authors.
|
Submit Corrections or Comments
|
|
In Silico |
Li et al., Aging, doi:10.18632/aging.103888 |
In Silico |
Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19 |
Details
Bioinformatics and network pharmacology analysis identifying potential mechanisms of action of vitamin A for COVID-19. |
|
Details
Source
PDF
In Silico
In Silico
|
Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19 |
Li et al., Aging, doi:10.18632/aging.103888 |
Bioinformatics and network pharmacology analysis identifying potential mechanisms of action of vitamin A for COVID-19.
Li et al., 8/15/2020, peer-reviewed, 7 authors.
In Silico studies are an important part of preclinical research, however results may be very different in vivo.
|
Submit Corrections or Comments
|
|
Review |
Andrade et al., SciELO preprints, doi:10.1590/SciELOPreprints.839 (Review) |
review |
Vitamin A and D deficiencies in the prognosis of respiratory tract infections: A systematic review with perspectives for COVID-19 and a critical analysis on supplementation |
Details
Systematic review showing deficiencies of vitamins A and D negatively affecting the prognosis of respiratory tract infections. |
|
Details
Source
PDF
Review
Review
|
Vitamin A and D deficiencies in the prognosis of respiratory tract infections: A systematic review with perspectives for COVID-19 and a critical analysis on supplementation |
Andrade et al., SciELO preprints, doi:10.1590/SciELOPreprints.839 (Review) |
Systematic review showing deficiencies of vitamins A and D negatively affecting the prognosis of respiratory tract infections.
Andrade et al., 6/24/2020, peer-reviewed, 6 authors.
|
Submit Corrections or Comments
|